scholarly journals Dutch Health Care Reform and^|^ldquo;Regulated Competition^|^rdquo;

1998 ◽  
Vol 7 (4) ◽  
pp. 99-129
Author(s):  
Masahiro Ohmori
Keyword(s):  
Health Care ◽  
Health Care Reform ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Regulated Competition

scholarly journals The politics of health-care reform in the Netherlands since 2006

2011 ◽  
Vol 6 (1) ◽  
pp. 125-134 ◽  
Author(s):  
Hans Maarse ◽  
Aggie Paulus
Keyword(s):  
Health Care ◽  
The Netherlands ◽  
Health Care Reform ◽  
Political Context ◽  
Market Reform ◽  
The Political ◽  
Political Resistance ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Political Compromise

AbstractThis article comments on Schut and van de Ven's overview of the results of purchaser competition in Dutch health care, which concludes that the glass can be seen as half full or half empty. Although it is true that results have been achieved, we believe that the evidence is incomplete and in some respects flimsy. More importantly, however, Schut and van de Ven neglect the political context of the market reform introduced in 2006. The reform is far from finished and there has been a constant need for political compromise. Optimism about the market's potential also seems to be on the wane. Several insurer and provider initiatives have provoked political resistance. As a result, there are good reasons to argue that the reform's future is uncertain.

scholarly journals Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system

2009 ◽  
Vol 4 (4) ◽  
pp. 405-424 ◽  
Author(s):  
J. HOLLAND ◽  
N.J.A. VAN EXEL ◽  
F.T. SCHUT ◽  
W.B.F. BROUWER
Keyword(s):  
Health Care ◽  
Health Insurance ◽  
Health Care System ◽  
Social Health Insurance ◽  
Convenience Sample ◽  
High Loss ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Gp Visits ◽  
Care System

AbstractTo contain expenditures in an increasingly demand driven health care system, in 2005 a no-claim rebate was introduced in the Dutch health insurance system. Since demand-side cost sharing is a very controversial issue, the no-claim rebate was launched as a consumer friendly bonus system to reward prudent utilization of health services. Internationally, the introduction of a mandatory no-claim rebate in a social health insurance scheme is unprecedented. Consumers were entitled to an annual rebate of ₠ 255 if no claims were made. During the year, all health care expenses except for GP visits and maternity care were deducted from the rebate until the rebate became zero. In this article, we discuss the rationale of the no-claim rebate and the available evidence of its effect. Using a questionnaire in a convenience sample, we examined people’s knowledge, attitudes, and sensitivity to the incentive scheme. We find that only 4% of respondents stated that they would reduce consumption because of the no-claim rebate. Respondents also indicated that they were willing to accept a high loss of rebate in order to use a medical treatment. However, during the last month of the year many respondents seemed willing to postpone consumption until the next year in order to keep the rebate of the current year intact. A small majority of respondents considered the no-claim rebate to be unfair. Finally, we briefly discuss why in 2008 the no-claim rebate was replaced by a mandatory deductible.

The Governance of Quality Management in Dutch Health Care

2013 ◽  
Vol 22 (3) ◽  
pp. 236-247 ◽  
Author(s):  
J. A. M. Maarse ◽  
D. Ruwaard ◽  
C. Spreeuwenberg
Keyword(s):  
Health Care ◽  
Quality Management ◽  
Dutch Health ◽  
Dutch Health Care

scholarly journals Evaluation of moral case deliberation at the Dutch Health Care Inspectorate: a pilot study

2016 ◽  
Vol 17 (1) ◽  
Author(s):  
Wike Seekles ◽  
Guy Widdershoven ◽  
Paul Robben ◽  
Gonny van Dalfsen ◽  
Bert Molewijk
Keyword(s):  
Health Care ◽  
Pilot Study ◽  
Moral Case Deliberation ◽  
Dutch Health ◽  
Dutch Health Care ◽  
Moral Case

scholarly journals Ineffable Cultures or Material Devices: What Valuation Studies can Learn from the Disappearance of Ensured Solidarity in a Health Care Market

2015 ◽  
Vol 3 (1) ◽  
pp. 45-73 ◽  
Author(s):  
Teun Zuiderent-Jerak ◽  
Stans Van Egmond
Keyword(s):  
Health Care ◽  
Decisive Role ◽  
Cultural Value ◽  
Health Care Market ◽  
A Value ◽  
Dutch Health ◽  
Short Time ◽  
Regulated Competition ◽  
Made In

Valuation studies addresses how values are made in valuation practices. A next - or rather previous - question becomes: what then makes valuation practices? Two oppositional replies are starting to dominate how that question can be answered: a more materially oriented focus on devices of valuation and a more sociologically inclined focus on ineffable valuation cultures. The debate between proponents of both approaches may easily turn into the kind of leapfrog debates that have dominated many previous discussions on whether culture or materiality would play a decisive role in driving history. This paper explores a less repetitive reply. It does so by analyzing the puzzling case of the demise of solidarity as a core value within the recent Dutch health care system of regulated competition. While “solidarity among the insured” was both a strong cultural value within the Dutch welfare-based health system, and a value that was built into market devices by health economists, within a fairly short time “fairness” became of lesser importance than “competition”. This makes us call for a more historical, relational, and dynamic understanding of the role of economists, market devices, and of culture in valuation studies.

Technology assessment, priority setting and appropriate care in Dutch health care

2004 ◽  
Vol 20 (4) ◽  
pp. 564-564 ◽  
Author(s):  
Marc Berg ◽  
Tom van der Grinten ◽  
Niek Klazinga
Keyword(s):  
Health Care ◽  
Decision Making ◽  
Comparative Analysis ◽  
Priority Setting ◽  
Technology Assessment ◽  
Economic Evaluations ◽  
Technol Assess Health ◽  
Appropriate Care ◽  
Dutch Health ◽  
Dutch Health Care

References 8, 29, and 32 are incorrect as they appear in the article entitled “Technology assessment, priority setting, and appropriate care in Dutch health care,” by Marc Berg, Tom van der Grinten, and Niek Klazinga (Int J Technol Assess Health Care. 2004;20[1]:35-43). They should appear as follows: 8. Burgers JS, Bailey JV, Klazinga NS, et al. Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002;11:1933-1939.29. Zwart-van Rijkom JE, Leufkens HG, Busschbach JJ, et al. Differences in attitudes, knowledge and use of economic evaluations in decision-making in The Netherlands. The Dutch results from the EUROMET Project. Pharmacoeconomics 2000;2:149-160.32. Van der Grinten TED. Hervorming van de gezondheidszorg. Zal het deze keer wel lukken? Beleid & Maatschappij 2002;3:172-176.

Sign in / Sign up

Export Citation Format

Share Document